Novo Nordisk
NVO
NZ$115.54
Share price
-3.77%
Change (1 day)
-46.97%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Earnings for Novo Nordisk (NVO)
Earnings in 2025 (TTM): NZ$34.07 Billion
According to Novo Nordisk's latest financial reports the company's current earnings are NZ$43.73 Billion. In 2024 the company made an earning of NZ$31.69 Billion, an increase over its 2023 earnings that were of NZ$25.79 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Novo Nordisk from 1984 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | NZ$34.07 B | 7.53% |
| 2024 | NZ$31.69 B | 22.84% |
| 2023 | NZ$25.79 B | 57.81% |
| 2022 | NZ$16.34 B | 5.24% |
| 2021 | NZ$15.53 B | 12.38% |
| 2020 | NZ$13.82 B | 13.11% |
| 2019 | NZ$12.22 B | -3.45% |
| 2018 | NZ$12.65 B | 1.88% |
| 2017 | NZ$12.42 B | 4.3% |
| 2016 | NZ$11.91 B | 10.32% |
| 2015 | NZ$10.79 B | 7.47% |
| 2014 | NZ$10.04 B | 3.4% |
| 2013 | NZ$9.71 B | 19.09% |
| 2012 | NZ$8.15 B | 15.58% |
| 2011 | NZ$7.05 B | 16.58% |
| 2010 | NZ$6.05 B | 25.66% |
| 2009 | NZ$4.81 B | 10.68% |
| 2008 | NZ$4.35 B | 55.82% |
| 2007 | NZ$2.79 B | 7.02% |
| 2006 | NZ$2.61 B | 19.05% |
| 2005 | NZ$2.19 B | 10.55% |
| 2004 | NZ$1.98 B | |
| 2002 | NZ$1.37 B | -14.39% |
| 2001 | NZ$1.60 B | -52.82% |
| 2000 | NZ$3.40 B | 250% |
| 1999 | NZ$0.97 B | 31.21% |
| 1998 | NZ$0.74 B | 34.31% |
| 1997 | NZ$0.55 B | 11.46% |
| 1996 | NZ$0.49 B | 9.03% |
| 1995 | NZ$0.45 B | -3.15% |
| 1994 | NZ$0.46 B | -0.67% |
| 1993 | NZ$0.47 B | 45.38% |
| 1992 | NZ$0.32 B | -13.81% |
| 1991 | NZ$0.37 B | 37.12% |
| 1990 | NZ$0.27 B | -0.79% |
| 1989 | NZ$0.27 B | 26.2% |
| 1988 | NZ$0.21 B | 24.97% |
| 1987 | NZ$0.17 B | -0.9% |
| 1986 | NZ$0.17 B | -7.78% |
| 1985 | NZ$0.19 B | 24.87% |
| 1984 | NZ$0.15 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | NZ$17.31 B | -48.63% | 🇺🇸 USA |
 Eli Lilly LLY | NZ$22.77 B | -32.43% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | NZ$10.22 B | -69.66% | 🇺🇸 USA |
 Sanofi SNY | NZ$14.68 B | -56.43% | 🇫🇷 France |